The pharmacist role in the development and implementation of a naloxone prescription program in Alabama

被引:10
|
作者
Wulz, Jordan L. [1 ]
Sung, Hanna [1 ]
Dugan, B. DeeAnn [1 ]
Wensel, Terri M. [1 ]
Lander, Roger [1 ]
Manzella, Bryn [2 ]
机构
[1] Samford Univ, McWhorter Sch Pharm, Birmingham, AL USA
[2] Jefferson Cty Dept Hlth, Qual Improvement, Birmingham, AL USA
关键词
OPIOID OVERDOSE;
D O I
10.1016/j.japh.2016.12.078
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: The purpose of this report is to describe the development and implementation of a pharmacist-led naloxone-training and prescription service at a county health department. Setting: Jefferson County Department of Health, Birmingham, Alabama. Practice description: This service was developed in response to the overwhelming heroin and opioid epidemic that is currently affecting the entire nation and which is highly prevalent in the state of Alabama. Because of this epidemic, new state laws have been established regarding prescriptive authority, liability, and possession of naloxone. Practice innovation: Through a collaborative protocol, pharmacists at the Jefferson County Department of Health were responsible for prescribing and educating the public about naloxone. Evaluation: Between 2014 and 2015 the Jefferson County Coroner reported a 131% increase in opioid prescription-related deaths indicating the continued need for the naloxone prescription program. Results: In total, 83 clients were trained and 150 naloxone kits were distributed among heroin and opioid users, concerned family members or friends, and those who work closely with users. Conclusion: This service and its extending arms were developed in response to the need for naloxone education among heroin and opioid users, their family members, civil servants who work with users, and family practice physicians who prescribe opioids. (C) 2017 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:S141 / S147
页数:7
相关论文
共 50 条
  • [2] Development and delivery of a pharmacist training program to increase naloxone access in Kentucky
    Palmer, Emma
    Hart, Steve
    Freeman, Patricia R.
    [J]. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2017, 57 (02) : S118 - S122
  • [3] Implementation of an antimicrobial stewardship program: the role of the clinical pharmacist
    Bellizzi, Marco
    Galfrascoli, Elena
    Davies, Sophia Elisabeth Campbell
    Muserra, Gaetana
    Saporito, Tommaso
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 326 - 327
  • [4] Implementation of a pharmacist skill development "work-with" program
    Rourke, Wallace
    Pagel, Kaitlyn
    Dumont, Zack
    Len, Suzanne
    Roy, Caitlin
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2023, 80 (01) : E29 - E45
  • [5] Development and implementation of a clinical pharmacist training and assessment program
    White, Allison M.
    Albertson, Brent
    Muncey, Lance
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (04) : 278 - +
  • [6] Expanding Access to Naloxone Role of the Pharmacist
    Gianutsos, Gerald
    [J]. US PHARMACIST, 2016, 41 (10)
  • [7] Naloxone for Opioid Overdose and the Role of the Pharmacist
    Toderika, Yuliana
    Williams, Shalonda
    [J]. CONSULTANT PHARMACIST, 2018, 33 (02): : 98 - 104
  • [8] Implementation of a Pharmacist-Led, Multidisciplinary Naloxone Patient Education Program at an Academic Medical Center
    Sze, Jennifer
    Chan, Tsz
    Dalpoas, Stacy
    Kiruthi, Catherine
    Harris, Che' Matthew
    Gundareddy, Venkat
    Parker, Marlena S.
    Jacob, Elsen
    [J]. JOURNAL OF PHARMACY PRACTICE, 2023, 36 (05) : 1201 - 1210
  • [9] Interprofessional development and implementation of a pharmacist professional advancement and recognition program
    Hager, David
    Chmielewski, Eric
    Porter, Andrea L.
    Brzozowski, Sarah
    Rough, Steve S.
    Trapskin, Philip J.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (22) : 1895 - 1902
  • [10] Expansion of an ED prescription naloxone program with SBIRT: A pilot program
    Moore, Q.
    Vergara-Rodriguez, P.
    Watts, J.
    Aks, S.
    [J]. CLINICAL TOXICOLOGY, 2014, 52 (07) : 719 - 719